NOVEL DRUG DELIVERY SYSTEMS II

Similar documents
Contents 1 Nanotechnology and Its Drug Delivery Applications

We make drugs smarter

Evonik Birmingham Laboratories

Contents 1 Mammalian Polysacharides and Its Nanomaterials

Advanced Biomaterials and Nanotechnologies in Drug Delivery

Handbook Controlled Release Of Drugs Polymers And Aggregate Systems

NanoAssemblr Benchtop. Develop Future Nanomedicines

Transdermal Drug in Adhesive Delivery Patch

1201 Maryland Avenue SW, Suite 900, Washington, DC ,

MASTER IN PHARMACEUTICAL SCIENCES (Thesis Track)

Empowering innovation.

At LATITUDE, we only do one thing, and we do it very well.

Chapter 1. Introduction

Drug Development and Incrementally Modified Drugs : Regulatory Perspective. American Association of Pharmaceutical Scientists October 27, 2015

FLUIDNATEK CUTTING EDGE ELECTROSPINNING & ELECTROSPRAYING DEVICES

Examination Assignments

CHAPTER INTRODUCTION 1.1 ORAL DRUG DELIVERY: SCOPE AND ADVANTAGES

MARINE BIOINFORMATICS & NANOBIOTECHNOLOGY - PBBT305

Molecules and Particles as Nano- and Micro-scale Drug Carriers

Course ADVANCED DRUG DELIVERY July 03-07, 2017 Faculty of Pharmacy Amphitheatre B Universidade de Lisboa, Portugal

Innovative drug delivery solutions for exceptional therapeutics APIDEL2017. ALL RIGHTS RESERVED.

The research work highlights the development and evaluation of. bioavailability of drugs. The buccal route can bypass the first-pass

The science of transforming an Active Pharmaceutical Ingredient (API) into a Drug Product (DP) in a specific dosage form.

Polymeric hydrogels are of special importance in polymeric biomaterials because of

UNIVERSITY OF ROME LA SAPIENZA NANOTECHNOLOGIES ENGINEERING NANOPARTICLES IN BIOMEDICINE

Nanotechnologie in der Lebensmittelindustrie

Biopharmaceutics Applications in Drug Development

L Intérêt du Projet CTI

CHAPTER 1 INTRODUCTION AND OBJECTIVES

EE 45X Biomedical Nanotechnology. Course Proposal

Types of Complex Formulations

Building the Europe of Knowledge

WHITE PAPER: Amorphous Solid Dispersions-One approach to improving Bioavailability

Centre for Bioactive Molecules and Drug Delivery (BMDD)

The strategy. using Atomic Force Microscope; Biomolecules and Neutraceuticals examples

NANOPARTICLES IN BIOTECHNOLOGY, DRUG DEVELOPMENT AND DRUG DELIVERY

Issues Related to the Formulation and Delivery of Pharmaceutical Proteins

Preface... iii Contents...vii Contributors...xv. 1 Introduction to Hot-Melt Extrusion, Continuous Manufacturing: Scale-up via Hot-Melt Extrusion...

NANO 243/CENG 207 Course Use Only

National Consultation on Nanomaterials and Their Implications on Human Health and Environment

BIOTECHNOLOGY. Biotechnology is the process by which living organisms are used to create new products THE ORGANISMS

Applications of self-assembling peptides in controlled drug delivery

BEH.462/3.962J Molecular Principles of Biomaterials Spring 2003

Extrusion: Pharmaceutical Applications

List of E-journals Subscribed for the year 2016 (January to December) Pharmacy Faculty Sl. No.

INNOVATIVE TECHNOLOGY IN MEDICINE: EXPERIENCE OF POLAND AND UKRAINE

Tentative Outline. Special Issue for Current Drug Delivery. Nanostructure based systems: Potential for Therapeutics, diagnostics and drug delivery

Biosimilars: The Impact on Academic Pharmacy

nanoprecipitation mpeg-pla 2 nd Emulsion mpeg-pla in DCM

Corporate. Established in Acquired facilities of: Competencies across the Generics & Biologics, value chain.

Special aspects of nanomedicines: Development, manufacturing and Characterisation

Controlled Release Drug Delivery from Hydrogels

PRONANOSOME SERIES. 1. Load. 2. Shake. 3. Nanovesicles are ready to use 1-LOAD 2-SHAKE READY. Applications

BSc Biomedical Science Degree

Custom Antibodies & Recombinant Proteins

Nanodiamond-Based Therapeutic Delivery Films For the Treatment of Cancer and Inflammation

Economic Growth through Research & Innovation: The Greek Pharma Case

GDUFA II Pre-ANDA Program Meetings for Complex Products

fact sheet 3 Introduction to Biosimilars & Regulatory Requirements

2.3 Quantum Dots (QDs)

Program outcomes MPHARM. Demonstrate understanding of basic sciences relevant to specialty.

Content Areas of the Pharmacy Curriculum Outcomes Assessment (PCOA )

Our Solutions for Protein Analysis

AIT/Athlone Institute of Technology

Practical Guide to Hot-Melt Extrusion: Continuous Manufacturing and Scale-up

Research and Innovation in Drug Discovery and Diagnostics

FORMULATING FOR MICRONEEDLE DELIVERY. Professor Finn Bauer

Healthcare. Healthcare. The Centre for Process Innovation. From innovation to commercialisation

USP s Perspective on Drug Product Performance Test

Pharmacist Rana Musa Al-ali (Malkawi) MSc (Pharmaceutical Quality Assurance) Registration Department/JFDA

INACTIVE INGREDIENTS DATABASE AND EMERGING DOSAGE FORMS. ExcipientFest 2016

Successful transfer of ligand binding assays between different laboratories

Advanced Pharmaceutical Manufacturing:

GDUFA RESEARCH AND REGULATORY INITIATIVES FOR COMPLEX TOPICAL PRODUCTS

How to Avoid Common Deficiencies in INDs and NDAs. Ramesh Raghavachari, Ph.D. Branch Chief, Branch IX ONDQA/OPS/CDER

D r. M O H A M M A D H O S S A I N S H A R I A R E

Howida Kamal, Ph.D. Ass. Prof. of Pharmaceutics, Cairo University

PHARMACEUTICAL PRINCIPLES OF SOLID DOSAGE FORMS

Emerging Drug Discovery Technologies

Chapter 8 Healthcare Biotechnology

Natassa Pippa, Stergios Pispas, Costas Demetzos

Regulatory Issues and Drug Product Approval for Biopharmaceuticals

IN VITRO RELEASE TESTING

Parioforma. Pharmaceutics Landscape - summary. (formerly RM Consulting) April 2005

INTER CHANGEABILITY and EQUIVALENCE. Where we are and what we still have to determine!

Formulation and invitro evaluation of albendazole nanosuspensions

INTRODUCTION 1. INTRODUCTION

Week 1: Discovery Biology Basic knowledge and tools used in Research and Development

ADVANCES IN PHARMACEUTICAL INDUSTRY FOR WELLNESS AND SUSTAINABLE HEALTH

BIOPHARMACEUTICALS Availability, Diffusion, Sustainability. Massimo Riccaboni University of Florence & CERM, Rome

SHANGHAI MEDICILON INC.

Guidelines for Pharmaceutical Equivalence Requirements

Innovative Pharmaceutical Solutions for Discovery Chemistry, Biology and cgmp Manufacturing

Nano-Robotics in Medicine: An Annotated Bibliography

Transdermal Drug Delivery System Regulatory Requirements (USA)

LIST OF ABBREVIATIONS

Bioengineering Research in Chemical Engineering

BSc BIOMEDICAL SCIENCE

Current Regulatory Thinking The Draft Reflection Paper On Intravenous Liposomal Product Quality Issues

Lonza Capital Markets Day Staying Ahead. Marc Funk COO Lonza Pharma & Biotech. Capital Markets Day September 2018

Transcription:

NOVEL DRUG DELIVERY SYSTEMS II Polymer Science 1. Define Polymer. Describe its properties. 2. Classify polymers based on various criteria. 3. What are the ideal characteristics of biodegradable polymers? Give advantages and disadvantages of biodegradable polymer in pharmaceuticals. 4. What is smart polymer? Discuss in brief giving suitable illustration. 5. Discuss the factors affecting degradation behavior of polymers. 6. Quantity of polymer can vary 1-70%, ultimate decision is from pharmacist, Comment on regulatory aspect for this. 7. Enlist various properties of polymer. Briefly describe the importance of Molecular weight and Glass Transition temperature of polymers. Discuss about the method for determination of molecular weight of polymers 8. Discuss the role of biodegradable polymers in drug delivery system and describe the mechanism of biodegradations. 9. Discuss inactive ingredient database 10. Write a note on polymers as solubilizing agents. 11. Give biodegradation mechanism of naturally occurring polymers. 12. Discuss hydrolysable polymers 13. Discuss polymers used in colon targeted drug delivery with suitable example. 14. Describe various polymers which undergo sol-gel transition. 15. Write pharmaceutical applications of polymers and discuss in brief polymer characterization. 16. Discuss in detail polymer properties.

Nanotechnology 1. Define nanotechnology and various products prepared by it. Explain application of nanoparticles and nanosuspensions giving examples for their market products. 2. Briefly introduce the term nanotechnology. Enlist the commonly used polymers into these products. Discuss any one method of preparation of nanoparticle. 3. Write about applications of nanoparticulate drug delivery system. 4. Give application of nanotechnology in the field of pharmaceutical science. 5. Explain the terms Nanotechnology and Nanoparticles. Enumerate different parameters and characterization methods for each parameter in context to characterization of Nanoparticulate system. Bioadhesive systems 1. Which are potential sites and dosage forms for bioadhesion? Draw a general schematic diagram for BDDS and classify them. Write a note on exvivo and in-vivo methods to study this system. 2. Discuss about theories related to Bioadhesion. 3. Discuss evaluation of bioadhesive drug delivery system. 4. Classify various factors affecting bioadhesion/mucoadhesion under separate/distinct heads and discuss in detail two factors from each head. 5. Define and explain bioadhesion, explain the theories of Bioadhesion and enumerate the properties of an ideal polymer for mucoadhesive drug delivery system Insitu gels 1. What is in-situ gel? Classify them and suggest its applications. 2. Discuss various approaches of in-situ gelation. 3. Note on: Insitu gels

Intelligent drug delivery systems and Tailor made medicines 1. What do you mean by intelligent DDS, explain giving suitable illustrations? 2. What is tailor-made medicine? Explain biomarker and theranostics with reference to medicine of 2050. 3. Write about applications of hydrogel in drug delivery system. 4. Enlist various intelligent drug delivery systems. Write about the system utilizing enzymes in context to intelligent drug delivery system. 5. What is intelligent drug delivery system? Give its application 6. Write a note on tailor-made drug delivery system. 7. Discuss in detail Intelligent drug delivery Strips, diskettes and film products 1. What is diskette? Classify them and discuss in brief the methods to evaluate them. 2. Compare films/strips with TDDS; write an idea about modified TDDS. 3. Define disketts. Write a note on buccal disketts. Liposomes and Niosomes 1. Enlist materials used in preparation of liposomes. Discuss about lipid characterization and control of liposomes. Compare emulsion with liposome as a system 2. Describe in brief the structure of Niosomes. Write about method of preparation of Niosomes. 3. Define liposome. Give classification of liposome. Discuss about the characterization of liposomes. 4. Discuss the problems associated with liposomes drug delivery system. 5. Discuss Sonication and French Pressure Cell (with the help of diagram) in context to methods of preparation of liposomes. 6. Define Liposomes, classify them (based on structural parameters) and discuss the applications of the same. 7. Note on: Proniosomes

Ionto and Sonophoretic system 1. Define sonophoresis. Differentiate between sonophoresis and iontophoresis. Discuss about drugs used by sonophoretic drug delivery system. 2. Explain electro-osmosis and electrorepulsive with reference to Iontophoresis. 3. Give advantages of using sonophoresis as a physical penetration enhancer 4. Define Iontophoresis. Discuss advantages, disadvantages, side effects and biomedical applications of the same. 5. Note on: Historical Development of Sonophoretic system. Use of Spherical Techniques 1. What is SCF? Discuss relative features of micronization by SCF technique and its application in Pharma research. 2. How does particle geometry affect Pharma processing? Discuss conventional and novel technology of spherical techniques in brief. 3. Enlist the methods of spherical crystallization. Discuss any one method of spherical crystallization and write applications of spherical crystallization. Super and Sub-Critical fluids 1. What is SCF? State the challenges of SCF. Write about applications of SCF in pharmaceutical research. 2. Give drug delivery applications of supercritical fluid technology 3. Note on: Commonly used Super Critical fluids PEGylations 1. What is PEGylation? How will you optimize manufacturing challenges and medical application of PEG-protein? 2. Briefly explain the concept of PEGlylation. Give factors affecting performance of PEGlyted peptide. Discuss about manufacturing challenges. 3. Write a note on PEGylation. 4. Discuss in detail PEGylations

Biotech based products 1. Write a note on γ-dna technology. 2. Write a note on cell and gene therapy products. 3. Enumerate various techniques used to produce biotechnological products. Write about rdna technology. Give examples of FDA approved rdna products. 4. Discuss any one biotech based product in detail Proteins and Peptides 1. Proteins and peptides are vulnerable to all sorts of problems those API can face. What are the strategies for oral delivery of protein? 2. Discuss about in-vivo and in-vitro problems associated with protein and peptide. Give your comment on formulation aspects of protein and peptide delivery system. 3. Discuss issues related to delivery of proteins and peptides. 4. Discuss challenges and stability problems in context to proteins and peptides. Immunomodulated approach 1. Write a note on Immunomodulated molecules Prodrug approach 1. Define Pro-drug Discuss pathways of them in therapeutics giving suitable examples. 2. Write potential of the prodrug approach 3. Discuss in detail polymer properties.